Carson Advisory Inc. Eli Lilly & CO Transaction History
Carson Advisory Inc.
- $145 Million
- Q2 2025
A detailed history of Carson Advisory Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Carson Advisory Inc. holds 647 shares of LLY stock, worth $482,901. This represents 0.35% of its overall portfolio holdings.
Number of Shares
647
Previous 622
4.02%
Holding current value
$482,901
Previous $513,000
1.75%
% of portfolio
0.35%
Previous 0.37%
Shares
15 transactions
Others Institutions Holding LLY
# of Institutions
4,404Shares Held
807MCall Options Held
9.91MPut Options Held
10.9M-
Pnc Financial Services Group, Inc. Pittsburgh, PA101MShares$75.6 Billion44.13% of portfolio
-
Lilly Endowment Inc Indianapolis, IN96MShares$71.7 Billion0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA79.2MShares$59.1 Billion1.22% of portfolio
-
Black Rock Inc. New York, NY65.9MShares$49.2 Billion1.37% of portfolio
-
State Street Corp Boston, MA34.4MShares$25.7 Billion1.2% of portfolio
About ELI LILLY & Co
- Ticker LLY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 950,174,976
- Market Cap $709B
- Description
- Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...